Arm Yourself Against the 2022-23 Flu Season
Cedars-SinaiAmid the loosening of COVID-19 precautions and a sharp increase in flu cases in the Southern Hemisphere, Cedars-Sinai experts are warning the public to prepare for a bad flu season this year.
Amid the loosening of COVID-19 precautions and a sharp increase in flu cases in the Southern Hemisphere, Cedars-Sinai experts are warning the public to prepare for a bad flu season this year.
Texas already has a moderately high rate of flu cases in September. This doesn’t look good for flu season, which was uncharacteristically low last year because of masks and people isolating. Houston Methodist experts are encouraging the community to get the flu shot early. Experts say cases aren't usually seen this high until December, which is when the season usually peaks.
Since becoming available, vaccines against COVID-19 have been vital in preventing deaths.
Irvine, Calif., Sept. 26, 2022 – The University of California, Irvine has been awarded a five-year, $13.8 million contract from the National Institute of Allergy and Infectious Diseases to conduct detailed immune profiling of lipid nanoparticles to increase understanding of their role in enhancing vaccine protective responses and in causing side effects.
With the rollout of boosters of life-saving vaccines, new treatments, and a large population already infected, the U.S. is in a less vulnerable place than it was in 2020. However, the death toll, while lower than before, is still at around 400 deaths per day from COVID-19 in the U.S.
FINDINGS Women with COVID in pregnancy who are subsequently vaccinated after recovery, but prior to delivery, are more likely to pass antibodies on to the child than similarly infected but unvaccinated mothers are. Researchers who studied a mix of vaccinated and unvaccinated mothers found that 78% of their infants tested at birth had antibodies.
In the early stages of the COVID-19 pandemic, the coronavirus was everywhere – stuck to our cellphone screens, smeared on our mail, dangling from doorknobs, even clinging to our cereal boxes. Except that it wasn’t. Despite public health guidance suggesting surfaces be disinfected to stop the spread of COVID-19, the virus wasn’t significantly transmitted through inanimate surfaces and objects, what microbiologists call “fomites.” As with all respiratory viruses – from the flu to the common cold – transmission was and remains almost exclusively airborne. Emanuel Goldman, a professor of microbiology at the Rutgers New Jersey Medical School, was among the first scientists to challenge conventional wisdom by warning that hygiene theater – overzealous disinfection of surfaces – had “become counterproductive” for public health.
A Providence study released online today in the Journal of the American Medical Association sheds new light on the added benefit of a booster dose of a COVID-19 mRNA vaccine among previously vaccinated individuals.
Researchers from Northern Arizona University and the University of Washington School of Medicine in collaboration with the Washington National Primate Research Center received a five-year, $7.5 million grant from the National Institutes of Health to fund a groundbreaking project that they hope will result in a safe and effective vaccine for Valley Fever.
A recently discovered virus in a Russian bat that is similar to SARS-CoV-2, the virus behind COVID-19, is likely capable of infecting humans and, if it were to spillover, is resistant to current vaccines.
National Comprehensive Cancer Network Advisory Committee on COVID-19 Vaccination and Pre-exposure Prophylaxis details clarified expert consensus to help guide providers on latest data and information, available at NCCN.org/covid-19.
LJI research shows that a "slow delivery, escalating dose" vaccination strategy can prompt B cells to spend months mutating and evolving their pathogen-fighting antibodies.
Jasmin A. Tiro, PhD, MPH, has joined the University of Chicago Medicine Comprehensive Cancer Center as the new Associate Director of Cancer Prevention and Population Sciences. Tiro was formerly Professor of Population and Data Sciences at Harold C. Simmons Comprehensive Cancer Center at the University of Texas Southwestern Medical Center in Dallas.
Though well-known as a respiratory illness, COVID-19 can also affect the nervous system. Now, researchers reporting in ACS Infectious Diseases have developed a new tool and possible vaccine candidate that could help scientists understand how SARS-CoV-2 could be invading these cells.
COVID-19 infection increases the risk of potentially life-threatening blood clots for at least 49 weeks, according to a new study of health records of 48 million unvaccinated adults from the first wave of the pandemic.
Acinetobacter baumannii is a bacterial pathogen responsible for serious hospital-related infections that is becoming increasingly resistant against antibiotics.
A Rutgers infectious disease expert explains why getting the annual flu shot is important to individual and public health
The Center for Disease Control’s National Center for Immunization and Respiratory Diseases has awarded University Hospitals of Cleveland a sizable grant to support its assignment as a study site in the United States Flu Vaccine Effectiveness Network.
Both an advisory from the American College of Obstetricians and Gynecologists and a new study encourage pregnant or lactating individuals to receive the latest COVID booster.
Sarah Knight, MD, Primary Care, Internal Medicine at Ochsner Health shares tips for staying healthy this flu season.
Current vaccination strategies are unlikely to eliminate measles, according to a new study led by faculty at the University of Georgia. The paper, which published today in The Lancet Global Health, explores the feasibility of eliminating measles and rubella using predominant vaccination strategies in 93 countries with the highest disease burden.
The David Geffen School of Medicine at UCLA has been awarded a $13.6 million grant from the Centers for Disease Control and Prevention to continue to study the effectiveness of COVID-19 vaccines and the long-term impact of infection among U.S. health care workers. The new yearlong grant project follows the 2020–21 Preventing Emerging Infections Through Vaccine Effectiveness Testing study, or PREVENT I, which was among the first to demonstrate the real-world benefit of mRNA vaccines in preventing symptomatic infection following their authorization by the Food and Drug Administration.
A new study uses a data-intelligent model to highlight the need to boost vaccination campaign budgets for disadvantaged, vulnerable populations to reach the maximum health benefit for everyone.
Key steps that everyone involved in pre-K - 12th grade schools can take to reduce the risk that COVID-19 will disrupt yet another school year.
Covid-19 vaccine companies influence each other's stock prices as well as market volatility, a team of scientists has found.
Despite recent claims on social media, the UK government has not changed its position on pregnant or breastfeeding women getting the COVID booster. The NHS says the vaccine is both safe and strongly recommended for this group.
To block infection from HIV, a successful vaccine will require a combination of ingredients, including at least three antibody targets and a substance that boosts immune responses. In a step toward achieving that goal, one potential vaccine component has led to strong protection in primates by eliciting an antibody that binds to part of the virus’s outer envelope, reports a team led by researchers at the Duke Human Vaccine Institute (DHVI).
In the first year of its availability, 84.2% of US adults received at least one dose of COVID-19 vaccine.
A published study of 1,899 pregnant women nationwide representing all 50 states reveals that during the Covid-19 pandemic if a pregnant woman had lower socioeconomic status and/or were African American, she was less likely to have the intention of taking a Covid-19 vaccine or actually receiving it.
The latest research and expert commentary on pain management.
Based on findings from a new study by a Johns Hopkins Medicine-led research team, an effective means of fighting SARS-CoV-2, the virus that causes COVID-19, may be possible that circumvents the problem of waning immunity often observed when current vaccines deal with emerging COVID variants.
Arizona State University rose three spots to No. 8 for U.S. utility patents issued to universities worldwide in 2021, continuing to help drive American technological evolution and success. This marks the second time that ASU ranked in the top 10 among universities worldwide and the fourth time that ASU ranked in the top 10 among U.S.-based universities in the annual ranking by the National Academy of Inventors and the Intellectual Property Owners Association.
Being vaccinated with at least two doses of Pfizer vaccines dramatically reduces most of the long-term symptoms individuals reported months after contracting COVID-19, a new study shows.
Neutralizing antibody levels against the original COVID-19 virus and omicron variants in vaccinated adults tend to decline by at least 15% per month after a single booster shot, a new study using serum from human blood samples suggests.
Getting an annual flu shot may be associated with a lower risk of stroke, according to a study published in the September 7, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Analysis across 67 countries highlights how among those who believe in COVID-19 conspiracy theories, a strong sense of morality increases support for COVID-19 prevention behaviors.
A new study from Israel found that the risk of developing myocarditis among males ages 16 to 19 years was about 1 in 15,000 after third dose of the Pfizer-BioNTech COVID-19 vaccine, and the cases were rare and mild, according to new research published today in the American Heart Association’s flagship journal Circulation.
Researchers analyzed how the expectation of a vaccine influences optimal lockdown measures during a pandemic.
SEATTLE — Sept. 1, 2022 — Below are summaries of recent Fred Hutchinson Cancer Center research findings and other news.Please note: On April 1, Fred Hutchinson Cancer Research Center merged with our care partner, Seattle Cancer Care Alliance. Our new name is Fred Hutchinson Cancer Center (Fred Hutch on subsequent references).
Two vaccine doses provide only limited and short-lived protection against SARS-CoV-2 infection with the Omicron variant. A study publishing September 1st in the open-access journal PLOS Medicine by Mie Agermose Gram at Statens Serum Institut, Copenhagen, Denmark, and colleagues suggests that a third COVID-19 vaccine dose increased the level and duration of protection against Omicron infection and hospitalization.
A Roundup of the Latest Medical Discoveries and Faculty News at Cedars-Sinai
The latest research on plants brought to you by Newswise.
Adding an ingredient called an adjuvant can help vaccines elicit a more robust immune response. In a study in ACS Infectious Diseases, researchers report a substance that boosted the immune response to an experimental COVID-19 shot in mice by 25 times, compared to injection with the vaccine alone.
The human papillomavirus (HPV) vaccine is safe and effective – but it’s not for everyone. Michelle Ozbun, PhD, and her team at UNM Cancer Center published a research article earlier this year in Antimicrobial Agents and Chemotherapy in which they describe how a drug called protamine sulfate blocks HPV infection. Like a game of musical chairs among molecules, the drug molecules bind to heparan sulfate cell receptors, preventing HPV virus particles from doing so.
A recent case of polio in the U.S. sounds the alarm for more vaccination.
The more effective the COVID-19 booster, the more likely people are to get it, according to new Cornell research. And they are more likely to accept the booster shot with cash incentives and if it is made by Moderna or Pfizer.
When the Biden administration announced COVID-19 vaccine mandates on Nov. 4 for businesses with 100 or more employees, protests erupted in cities across the U.S.